Kenya - English - Pharmacy and Poisons Board

glaxosmithkline pharmaceutical kenya limited likoni rd industrial area p.o box 78392 - combined diphtheria-tetanus-acellular pertussis… - powder and suspension for suspension for inje - one dose (0.5ml) - combinations of bacterial and viral vaccines

Kenya - English - Pharmacy and Poisons Board

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - diphtheria tetanus pertussis (acellular… - powder for suspension for injection - after reconstitution one dose (0.5 ml) contains: … - combinations of bacterial and viral vaccines

Kenya - English - Pharmacy and Poisons Board

sanofi healthcare india private limited survey no. 274, athvelli village, medchal mandal - diphtheria toxoid,tetanus toxoid,whole cell… - suspension for injection in pre-filled syring - each 0.5 ml dose of vaccine contains:diphtheria… - combinations of bacterial and viral vaccines

Kenya - English - Pharmacy and Poisons Board

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - diphtheria tetanus pertussis (acellular… - suspension for injection in pre-filled syring - one dose (0.5 ml) contains: diphtheria toxoid 30… - combinations of bacterial and viral vaccines

Israel - English - Ministry of Health

medici ltd - diphtheria toxoid 2 iu / 0.5 ml; poliomyelitis virus type 1 40 du/dose - suspension for injection - diphtheria-poliomyelitis-tetanus - this combined vaccine is indicated for adults as a booster of a previous vaccination for the simultaneous prevention of diphtheria tetanus and poliomyelitis. refer to the official recommendations for vaccination schedules. this vaccine may be administered as a booster of a previous vaccination to children 6 or older in exceptional cases particularly in the case of a shortage of the diphtheria tetanus and poliovirus vaccine (dtpolio) recommended in the vaccination schedule.

Israel - English - Ministry of Health

sanofi israel ltd - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn); pertussis toxoid vaccine; tetanus toxoid - suspension for injection - fimbrae tupes 2 + 3 (fim) 5 mcg/dose; pertussis toxoid vaccine 2.5 mcg/dose; filamentous haemagglutinin (fha) 5 mcg/dose; pertactin (prn) 3 mcg/dose; diphtheria toxoid 2 lf / 1 doses; tetanus toxoid 5 lf / 1 doses; inactivated polio virus (ipv) type 1 40 du/dose; inactivated polio virus (ipv) type 2 8 du/dose; inactivated polio virus (ipv) type 3 32 du/dose - diphtheria-pertussis-poliomyelitis-tetanus - diphtheria-pertussis-poliomyelitis-tetanus - active immunization against diphtheria, tetanus, pertussis and poliomyelitis in subjects aged 4 years and over as a booster following primary immunisation.adacel polio is not indicated for primary immunisation. adacel polio is not indicated for treating diseases caused by b.pertussis, c.diphtheriae or c.tetani or by poliomyelitis infections

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - purified diphtheria toxoid ph. eur., purified tetanus toxoid, adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus, haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0 %v/v - bacterial and viral vaccines, combined

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - purified tetanus toxoid, purified diphtheria toxoid ph. eur., adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus - suspension for injection - bacterial and viral vaccines, combined

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - diphtheria toxoid - injection - 15 lf/0.5 ml

Malta - English - Malta Medicines Authority

sanofi pasteur s.a. - poliovirus (inactivated) type 1 (mahoney strain) 40 dagu, poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu, poliovirus (inactivated) type 3 (saukett strain) 32 dagu, diphtheria toxoid, tetanus toxoid - suspension for injection in pre-filled syringe